Roche wins first U.S. approval of immunotherapy for breast cancer - STAT

Roche wins first U.S. approval of immunotherapy for breast cancer - STAT

Roche scores first U.S. approval of immunotherapy for breast cancer

By SHARON BEGLEY

ANNE WESTON/FRANCIS CRICK INSTITUTE/WELLCOME

The approval was based on progression-free survival and on the fact that patients with advanced triple-negative breast cancer have essentially no options,

READ MORE